Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.24(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1661
+0.0009(+0.08%)
GBP/USD
1.2549
+0.0003(+0.02%)
Bitcoin GBP
51,355.30
+841.11(+1.67%)

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Sensus Healthcare, Inc. (SRTS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

3.6500

-0.2100

(-5.44%)

At close: 04:00PM EDT

3.7000

+0.05

(+1.37%)

After hours:

05:22PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	59.84M
Enterprise value	37.47M
Trailing P/E	121.67
Forward P/E	45.66
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.43
Price/book (mrq)	1.23
Enterprise value/revenue	1.54
Enterprise value/EBITDA	474.35

Trading information

Stock price history

Beta (5Y monthly)	0.94
52-week change ³	29.53%
S&P500 52-week change ³	22.38%
52-week high ³	5.3800
52-week low ³	1.7900
50-day moving average ³	3.7257
200-day moving average ³	3.0355

Share statistics

Avg vol (3-month) ³	150.87k
Avg vol (10-day) ³	76.59k
Shares outstanding ⁵	16.39M
Implied shares outstanding ⁶	17.34M
Float ⁸	13.07M
% held by insiders ¹	21.40%
% held by institutions ¹	16.84%
Shares short (15 Apr 2024) ⁴	33.38k
Short ratio (15 Apr 2024) ⁴	0.31
Short % of float (15 Apr 2024) ⁴	0.23%
Short % of shares outstanding (15 Apr 2024) ⁴	0.20%
Shares short (prior month 15 Mar 2024) ⁴	65.8k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2021

Profitability

Profit margin	1.99%
Operating margin (ttm)	40.84%

Management effectiveness

Return on assets (ttm)	-0.43%
Return on equity (ttm)	1.00%

Income statement

Revenue (ttm)	24.41M
Revenue per share (ttm)	1.50
Quarterly revenue growth (yoy)	155.70%
Gross profit (ttm)	N/A
EBITDA	-107k
Net income avi to common (ttm)	485k
Diluted EPS (ttm)	0.0300
Quarterly earnings growth (yoy)	422.40%

Balance sheet

Total cash (mrq)	14.52M
Total cash per share (mrq)	0.87
Total debt (mrq)	225k
Total debt/equity (mrq)	0.87%
Current ratio (mrq)	11.76
Book value per share (mrq)	1.57

Cash flow statement

Operating cash flow (ttm)	-2.15M
Levered free cash flow (ttm)	-1.82M